These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 20131186

  • 21. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T, Xie Y, Zhou YJ, Li YP, Ma HY, Guo YH, Liu YY, Zhao YX, Shi DM.
    Chin Med J (Engl); 2009 Aug 05; 122(15):1732-7. PubMed ID: 19781316
    [Abstract] [Full Text] [Related]

  • 22. Effect of mean platelet volume on postintervention coronary blood flow in patients with chronic stable angina pectoris.
    Duygu H, Turkoglu C, Kirilmaz B, Turk U.
    J Invasive Cardiol; 2008 Mar 05; 20(3):120-4. PubMed ID: 18316827
    [Abstract] [Full Text] [Related]

  • 23. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.
    Freeman M, Clark DJ, Andrianopoulos N, Duffy SJ, Lim HS, Brennan A, Charter K, Shaw J, Horrigan M, Ajani AE, Sebastian M, Reid CM, Farouque HM, Melbourne Interventional Group.
    Catheter Cardiovasc Interv; 2009 May 01; 73(6):763-8. PubMed ID: 19309731
    [Abstract] [Full Text] [Related]

  • 24. Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction.
    Heggunje PS, Harjai KJ, Stone GW, Mehta RH, Marsalese DL, Boura JA, O'Neill WW, Grines CL.
    J Am Coll Cardiol; 2004 Oct 06; 44(7):1400-7. PubMed ID: 15464319
    [Abstract] [Full Text] [Related]

  • 25. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease.
    van Domburg RT, Lemos PA, Takkenberg JJ, Liu TK, van Herwerden LA, Arampatzis CA, Smits PC, Daemen J, Venema AC, Serruys PW, Bogers AJ.
    Eur Heart J; 2005 Apr 06; 26(7):675-81. PubMed ID: 15637087
    [Abstract] [Full Text] [Related]

  • 26. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D, Di Salvo ME, Capranzano P, Seminara D, Caggegi A, Barrano G, Tamburino C.
    Minerva Cardioangiol; 2009 Feb 06; 57(1):1-6. PubMed ID: 19202514
    [Abstract] [Full Text] [Related]

  • 27. Measurement of fractional flow reserve in patients with multi-vessel coronary artery disease and borderline lesions prevents unnecessary revascularisation procedures.
    Reczuch K, Jankowska E, Telichowski A, Porada A, Banasiak W, Ponikowski P.
    Kardiol Pol; 2004 Apr 06; 60(4):311-19; discussion 320-1. PubMed ID: 15226780
    [Abstract] [Full Text] [Related]

  • 28. Prognostic value of exercise stress test and dobutamine stress echo in patients with known coronary artery disease.
    Innocenti F, Caldi F, Tassinari I, Agresti C, Burgisser C, Fattirolli F, Baldereschi GJ, Marchionni N, Masotti G, Pini R.
    Echocardiography; 2009 Jan 06; 26(1):1-9. PubMed ID: 19017329
    [Abstract] [Full Text] [Related]

  • 29. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome.
    Chyrchel M, Rakowski T, Rzeszutko L, Legutko J, Dziewierz A, Dubiel JS, Dudek D.
    Kardiol Pol; 2006 Dec 06; 64(12):1357-62; discussion 1363. PubMed ID: 17206539
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Stent implantation for the unprotected left main coronary artery. The long-term outcome of 62 patients.
    Peszek-Przybyła E, Buszman P, Białkowska B, Zurakowski L, Banasiewicz-Szkróbka I, Debiński M, Tendera M.
    Kardiol Pol; 2006 Jan 06; 64(1):1-6; discussion 7. PubMed ID: 16444619
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A questionnaire-based assessment of daily physical activity in heart failure.
    Garet M, Barthélémy JC, Degache F, Costes F, Da-Costa A, Isaaz K, Lacour JR, Roche F.
    Eur J Heart Fail; 2004 Aug 06; 6(5):577-84. PubMed ID: 15302005
    [Abstract] [Full Text] [Related]

  • 38. Effects of exercise prescription on daily physical activity and maximal exercise capacity in coronary artery disease patients with and without type 2 diabetes.
    Karjalainen JJ, Kiviniemi AM, Hautala AJ, Niva J, Lepojärvi S, Mäkikallio TH, Piira OP, Huikuri HV, Tulppo MP.
    Clin Physiol Funct Imaging; 2012 Nov 06; 32(6):445-54. PubMed ID: 23031065
    [Abstract] [Full Text] [Related]

  • 39. [Daily physical activity in adult patients with cystic fibrosis].
    Prévotat A, Denis F, Leroy S, Garet M, Wemeau-Stervinou L, Perez T, Halm AM, Wallaert B.
    Rev Pneumol Clin; 2013 Feb 06; 69(1):3-9. PubMed ID: 23333050
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.